Zaire Ebolavirus Glycoprotein-directed Antibody drugs

1 medication in the FDA established pharmacologic class “Zaire Ebolavirus Glycoprotein-directed Antibody”.

DrugTypeNDC products
Ebanga
Ansuvimab
Rx1